OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - STRYKER CORP. Share Price

Certificat

DE000SV5D718

Market Closed - Boerse Frankfurt Warrants 20:40:30 21/06/2024 BST
0.73 EUR 0.00% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - STRYKER CORP.
Current month-2.67%
1 month-10.98%
Date Price Change
21/06/24 0.73 0.00%
20/06/24 0.73 +17.74%
19/06/24 0.62 -6.06%
18/06/24 0.66 -4.35%
17/06/24 0.69 -1.43%

Real-time Boerse Frankfurt Warrants

Last update June 21, 2024 at 08:40 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SV5D71
ISINDE000SV5D718
Date issued 21/04/2023
Strike 419.6 $
Maturity Unlimited
Parity 100 : 1
Emission price 1.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.56
Lowest since issue 0.52
Spread 0.01
Spread %1.39%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
342.6 USD
Average target price
372.9 USD
Spread / Average Target
+8.84%
Consensus